Case Development

Market Opportunity Analysis

Forecast Modeling

 

Early Stage Strategic Planning

Portfolio Planning

Target Product Profile Development

Scientific Platform/Medical Story

Unmet needs mapping

Patient Flow

Life-cycle Planning

Marketing Process Developmen

 

Strategies for an Evolving Pharmaceutical Industry

Philosophy

The pharmaceutical industry has shifted and continues to evolve……creating significant headwinds for new product launches.  Peak sales expectations are getting smaller and smaller with nearly half of all product launches topping out at $200 million or less, and over two-thirds failing to meet pre-launch expectations.1

Achieving commercial goals in a rapidly evolving environment often with less time and fewer resources requires an acknowledgement that the rules of the game have changed.  We can no longer rely solely on traditional strategies and tactics to solve business problems or take advantage of an opportunity…. but the time and resources needed to figure out a completely different approach is scarce!

I3 Strategy Partners helps you study your most pressing business challenge or question and “crack the code” on what strategies will work uniquely to unlock the full potential of your brand or organization.

 

1.  Evaluate Pharma; McKinsey Analysis

WHY I3

We’ve seen the world through your eyes!  We are experienced former pharmaceutical leaders with recent success in the changing healthcare environment. That means we are well positioned to efficiently get to the bottom of your business question by collecting and connecting the most relevant dots and synthesizing the implications based on an actual vs. theoretical understanding of the business.  And, since we’ve led implementation first hand, you can be assured that any strategies we recommend are feasible.

OUR APPROACH

Once you tell us your most pressing challenge/opportunity, we apply a proven formula that enables us to:

  • Uncover deep and actionable Insights
  • Determine relevant Implications
  • Design comprehensive Implementation plans

We then help you gain internal support for your plan through Storytelling.  We’ll work together to develop compelling presentations for use with senior leaders and/or board members whose support you need to resource your plan, as well as cross-functional teams who need a clear understanding in order to implement it.

Of course, we’ll still provide the comprehensive information generated during the project, but instead of expecting you to present the information as is, we’ll crystallize it into a simple, engaging, memorable story you can tell that will resound with key stakeholders. x

OUR TEAM

We have assembled an insights team comprised of qualitative and quantitative market researchers, analytics experts and strategists to fuel the I3 approach.  We employ a flexible staffing model that allows us to efficiently staff up or down as needed depending on your needs.

 

OUR LEADERSHIP

Ann Cunningham

Founder and Managing Partner

 

Experience

  • Vice President, Neurodegenerative Disease and Psychiatry - Teva Pharmaceutical, Inc.
  • Senior Director, Global Brand Lead, Rexulti - Otsuka America Pharmaceutical, Inc.
  • Senior Director, Global Brand Lead, Bone/Muscle/Joint Portfolio - Lilly
  • Sales Director, Cardiovascular - Lilly
  • Sales Director, Psychiatry – Lilly
  • Director, Consumer Marketing, Cymbalta – Lilly

Education

  • Michigan Business School, MBA
  • Yale University, BA

 

Ann has spent 20+ years harnessing the power of the 3 Is (Insight, Implications, and Implementation) to plan and execute successful portfolio strategies and brand launches.  She has a passion for looking deeply at business questions and “cracking the code” with innovative solutions while, at the same time, leveraging the fundamentals.  One of her most notable successes involved leading the team that searched relentlessly to find the insight behind the Cymbalta “Depression Hurts” DTC campaign, an effort that motivated depressed patients to ask for Cymbalta by name, ultimately changing the growth trajectory of the brand.  She founded I3 Strategy Partners so she can spend more time helping business leaders identify and leverage those foundational insights and implications that underpin any successful brand or portfolio plan.

SERVICES

Whether you have a pressing business question that I3 can help you solve or a specific business need for one of the services below……we can help enable effective decision-making at every step in the brand development process, from the inception of the brand through loss of exclusivity.

Early Stage

  • Market Opportunity Analyses
  • In-license valuation
  • Forecast Modeling/NPV Assessments
  • Target Product Profile (TPP) Development
  • Life-cycle Planning
  • Scientific Platform/Medical Story

 

Marketing Planning

  • Segmentation and Patient Journey
  • DTC Development and Planning
  • Payer Value Proposition
  • KOL and Advocacy Engagement
  • Marketing Planning Process Development

Post-launch Excellence

  • Label Enhancement Strategies
  • Channel Mix Effectiveness
  • Sales Force Effectiveness
  • Brand Intervention/Turnaround Planning
  • Business Performance Analytics

Contact Us

Phone:  (610) 873-0187

Privacy Policy

 

 

Submitting Form...

The server encountered an error.

Form received.

I3 Strategy Partners helps you study your most pressing business challenge or question and “crack the code” on what strategies will work uniquely to unlock the full potential of your brand or organization.

OUR TEAM

We have assembled an insights team comprised of qualitative and quantitative market researchers, analytics experts and strategists to fuel the I3 approach.  We employ a flexible staffing model that allows us to efficiently staff up or down as needed depending on your needs.

 

OUR LEADERSHIP

Ann Cunningham

Founder and Managing Partner

 

Experience

  • Vice President, Neurodegenerative Disease and Psychiatry - Teva Pharmaceutical, Inc.
  • Senior Director, Global Brand Lead, Rexulti - Otsuka America Pharmaceutical, Inc.
  • Senior Director, Global Brand Lead, Bone/Muscle/Joint Portfolio - Lilly
  • Sales Director, Cardiovascular - Lilly
  • Sales Director, Psychiatry – Lilly
  • Director, Consumer Marketing, Cymbalta – Lilly

Education

  • Michigan Business School, MBA
  • Yale University, BA

 

Ann has spent 20+ years harnessing the power of the 3 Is (Insight, Implications, and Implementation) to plan and execute successful portfolio strategies and brand launches.  She has a passion for looking deeply at business questions and “cracking the code” with innovative solutions while, at the same time, leveraging the fundamentals.  One of her most notable successes involved leading the team that searched relentlessly to find the insight behind the Cymbalta “Depression Hurts” DTC campaign, an effort that motivated depressed patients to ask for Cymbalta by name, ultimately changing the growth trajectory of the brand.  She founded I3 Strategy Partners so she can spend more time helping business leaders identify and leverage those foundational insights and implications that underpin any successful brand or portfolio plan.